Gilead Sciences Inc diskutieren
Gilead Sciences Inc
WKN: 885823 / Symbol: GILD / Name: Gilead Sciences / Aktie / Biotechnologie & medizinische Forschung / Large Cap /
105,04 €
0,46 %
Gilead Sciences (NASDAQ:GILD) had its price target raised by analysts at Wells Fargo & Company from $145.00 to $150.00. They now have an "overweight" rating on the stock.
Ratings data for GILD provided by MarketBeat
Gilead Sciences (NASDAQ:GILD) had its price target raised by analysts at Morgan Stanley from $147.00 to $151.00. They now have an "overweight" rating on the stock.
Ratings data for GILD provided by MarketBeat
Gilead Sciences (NASDAQ:GILD) was given a new $135.00 price target on by analysts at Sanford C. Bernstein. They now have an "outperform" rating on the stock.
Ratings data for GILD provided by MarketBeat
Gilead Sciences (NASDAQ:GILD) had its "buy" rating reaffirmed by analysts at UBS Group AG. They now have a $145.00 price target on the stock, up previously from $112.00.
Ratings data for GILD provided by MarketBeat
Gilead Sciences (NASDAQ:GILD) had its price target raised by analysts at Citigroup Inc. from $135.00 to $140.00. They now have a "buy" rating on the stock.
Ratings data for GILD provided by MarketBeat
Gilead Sciences (NASDAQ:GILD) had its "outperform" rating reaffirmed by analysts at BMO Capital Markets.
Ratings data for GILD provided by MarketBeat
Gilead Sciences (NASDAQ:GILD) had its price target lowered by analysts at Morgan Stanley from $151.00 to $150.00. They now have an "overweight" rating on the stock.
Ratings data for GILD provided by MarketBeat
Neueste Beiträge
Cowen_Inc in Affiliated Managers Group diskutieren